• News
  • Medical

Lpath receives US patent for ocular conditions

San Diego-based Lpath Inc. (Nasdaq: LPTN), a developer of bioactive lipid-targeted therapeutics, has received official notification from the U.S. Patent and Trademark Office that it has been issued another key patent supporting its iSONEP program.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!